These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15802167)

  • 21. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe community-acquired pneumonia: approach to therapy.
    Pineda L; El Solh AA
    Expert Opin Pharmacother; 2007 Apr; 8(5):593-606. PubMed ID: 17376015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.
    Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN
    Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
    Laterre PF
    Clin Infect Dis; 2008 May; 46(10):1510-2. PubMed ID: 18419483
    [No Abstract]   [Full Text] [Related]  

  • 25. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization.
    Peyrani P; Wiemken TL; Metersky ML; Arnold FW; Mattingly WA; Feldman C; Cavallazzi R; Fernandez-Botran R; Bordon J; Ramirez JA
    Infect Dis (Lond); 2018 Jan; 50(1):13-20. PubMed ID: 28699429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].
    Höffken G; Lorenz J; Kern W; Welte T; Bauer T; Dalhoff K; Dietrich E; Ewig S; Gastmeier P; Grabein B; Halle E; Kolditz M; Marre R; Sitter H
    Dtsch Med Wochenschr; 2010 Feb; 135(8):359-65. PubMed ID: 20166002
    [No Abstract]   [Full Text] [Related]  

  • 27. How long should we treat community-acquired pneumonia?
    Scalera NM; File TM
    Curr Opin Infect Dis; 2007 Apr; 20(2):177-81. PubMed ID: 17496577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved management of community-acquired pneumonia in the emergency department.
    Julián-Jiménez A; Palomo de los Reyes MJ; Parejo Miguez R; Laín-Terés N; Cuena-Boy R; Lozano-Ancín A
    Arch Bronconeumol; 2013 Jun; 49(6):230-40. PubMed ID: 23477946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
    Matsushima T;
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
    [No Abstract]   [Full Text] [Related]  

  • 31. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 32. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Weiss K; Tillotson GS
    Chest; 2005 Aug; 128(2):940-6. PubMed ID: 16100190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity assessment in community-acquired pneumonia.
    Ewig S; Schäfer H; Torres A
    Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial therapy of outhospital pneumonia in military treatment-prophylactic institutions].
    Sinopal'nikov AI; Rachina SA; Iashchenko AV; Shal' EP
    Voen Med Zh; 2009 Feb; 330(2):14-20. PubMed ID: 19351019
    [No Abstract]   [Full Text] [Related]  

  • 35. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
    Arnold FW; Wiemken TL; Peyrani P; Ramirez JA; Brock GN;
    Respir Med; 2013 Jul; 107(7):1101-11. PubMed ID: 23660396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of community-acquired pneumonia in hospitalised patients.
    Mulazimoglu L
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S63-70. PubMed ID: 11574198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Duration of treatment and oral administrad on of antibiotics in community acquired pneumonia].
    Bernal-Vargas MA; Cortés JA
    Rev Chilena Infectol; 2016 Apr; 33(2):177-86. PubMed ID: 27314995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Marrie TJ
    Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic therapy for inpatients with community-acquired pneumonia in a developing country.
    Trinh HT; Hoang PH; Cardona-Morrell M; Nguyen HT; Vu DH; Dong PT; Cao TT; Nguyen ST; Pham VT; Moss L; Dinh K; Dartnell J; Nguyen HT
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):129-36. PubMed ID: 24648269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.